NASDAQ:EBIO
Delisted

Eleven Biotherapeutics Fund Price (Quote)

$3.29
+0 (+0%)
At Close: May 31, 2018

Range Low Price High Price Comment
30 days $2.52 $3.50 Thursday, 31st May 2018 EBIO stock ended at $3.29. During the day the stock fluctuated 0% from a day low at $3.29 to a day high of $3.29.
90 days $0.90 $3.50
52 weeks $0.620 $3.50

Historical Eleven Biotherapeutics prices

Date Open High Low Close Volume
Jan 13, 2016 $2.38 $2.48 $2.28 $2.29 51 600
Jan 12, 2016 $2.23 $2.63 $2.23 $2.44 65 800
Jan 11, 2016 $2.35 $2.35 $2.18 $2.21 32 800
Jan 08, 2016 $2.52 $2.54 $2.46 $2.48 23 900
Jan 07, 2016 $2.62 $2.65 $2.50 $2.55 55 400
Jan 06, 2016 $2.75 $2.78 $2.65 $2.67 54 900
Jan 05, 2016 $2.87 $2.88 $2.70 $2.82 66 800
Click to get the best stock tips daily for free!

About Eleven Biotherapeutics

Eleven Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of protein therapeutics to treat eye diseases primarily in the United States. The company develops its therapeutics through AMP-Rx, a proprietary protein engineering platform. Its lead product candidate is EBI-005, which has completed Phase III clinical trials for the treatment of patients with dry eye disease and allergic conjunctivitis. The compa... EBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT